Bioanalysis for Foundations and Patient Groups

Most CROs aren't built for foundation-led research. They impose 100+ sample minimums, quote turnaround times in months, and provide pricing that changes after the contract is signed.

We built Dash Bio to work differently. Our automated platform delivers GLP-compliant results in weeks instead of months, with transparent pricing and a 30-sample minimum that makes smaller studies practical.

The right partner for Foundations and Patient Groups

30-sample minimum – Access bioanalysis without scale barriers

10x faster turnaround – Results in weeks, not months

100% transparent pricing – Complete costs upfront, no surprises

Access Without Scale Barriers

Traditional CROs require 100 to 500 samples to take on a project. We start at 30 samples, making bioanalysis accessible for pilot studies, registry research, and natural history studies where sample size is limited by disease prevalence rather than statistical planning.

Speed That Matches Your Timeline

Patient advocacy happens on a different clock than pharmaceutical development. When you're coordinating samples from multiple sites or trying to influence a clinical trial design, a 4-month turnaround isn't helpful. Our automated platform delivers GLP-compliant results in 2 to 4 weeks.

Pricing You Can Plan Around

No hidden fees, no change orders, no surprise costs after you've committed. We provide complete pricing upfront, including method development, validation, and sample analysis. You'll know exactly what your study costs before you submit your first sample.

When This Matters Most

Biomarker Qualification Studies

Testing a new biomarker before it goes into pivotal trials requires precise quantification at a scale that doesn't justify traditional CRO economics. We handle small validation cohorts where the science matters more than the volume.

Natural History Studies

Rare disease registries generate samples steadily over time rather than in large batches. Our flexible capacity handles ongoing analysis without forcing you into a minimum batch size that doesn't match your enrollment rate.

Investigator-Initiated Trials

Academic collaborations often work with constrained budgets and tight submission deadlines. We provide the same GLP-compliant rigor as large pharma studies, priced for feasibility studies and pilot trials.

How Pricing Works

Method Development

Fixed cost based on assay complexity. Includes optimization, matrix selection, and preliminary validation data. You'll receive a detailed development plan with timeline and deliverables before work begins.

Validation

Transparent per-run pricing for qualification or full validation. No hidden costs for reanalysis or documentation. You know the complete validation cost before starting.

Sample Analysis

Per-sample pricing with volume discounts starting at 30 samples. Includes repeat analysis if needed, ISR, and complete regulatory documentation. No fees for data queries or amendments.

What GLP Compliance Means

All work is performed under our GLP quality system. This means documented procedures, calibrated instruments, trained analysts, and complete audit trails. Your data meets regulatory standards whether you're supporting an IND filing or publishing in peer-reviewed journals.

We provide the same documentation packages used by pharmaceutical sponsors, adapted for foundation research. Study reports, raw data, and method validation summaries are included in every project.

Start a Conversation

Tell us about your study. We'll provide a detailed quote within 48 hours.